Epigral approves Rs 600-cr capex for new manufacturing facility in GujaratIllustrative image – not actual.

Epigral’s Board of Directors has approved a Rs 600 crore capital expenditure plan to establish a new manufacturing facility at its existing Dahej site in Gujarat.

The expansion is aimed at strengthening the company’s product portfolio and meeting rising demand for epoxy-based products across various industries. The project will add 1,25,000 tonne per annum (TPA) capacity for Epoxy Resin and Formulations, with commercial operations expected to begin in the second half of FY2028. Along with the dedicated epoxy facility, Epigral will also develop a multi-purpose plant (MPP), which is scheduled to become operational during the same period. The investment will be funded through a combination of debt and internal accruals, allowing the company to maintain financial flexibility while pursuing long-term growth opportunities. The Dahej location provides strategic advantages due to its established chemical ecosystem, access to raw materials and connectivity for distribution.

By adding epoxy manufacturing capabilities and a flexible multi-purpose facility, the company aims to cater to a wider customer base and strengthen its position in India’s specialty chemicals sector.

 

← All latest storiesBack to top →